STAT+: Flagship, Orbimed, ARCH, Alta top list of high-performing biotech venture capital firms
Flagship Pioneering is on track to return its investors’ money an eye-popping 15 times over, according to public records gathered by STAT.
The Cambridge-based firm’s fourth fund, which officially launched in 2012, reported the highest investment multiple of any fund included in a new STAT report published on Monday that looks at returns for 17 major biotech venture capital firms during 2020.
Continue to STAT+ to read the full story…
